NPI: 1942248737 · GARFIELD HEIGHTS, OH 44125 · General Acute Care Hospital · NPI assigned 06/03/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 06/03/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 54,590 | $2.08M |
| 2019 | 52,481 | $2.07M |
| 2020 | 40,633 | $2.77M |
| 2021 | 60,113 | $3.57M |
| 2022 | 64,587 | $2.97M |
| 2023 | 259,388 | $8.88M |
| 2024 | 190,077 | $5.67M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 16,965 | 13,508 | $4.87M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 39,183 | 36,081 | $4.54M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 41,235 | 38,973 | $4.49M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 35,132 | 30,875 | $4.42M |
| 70450 | Computed tomography, head or brain; without contrast material | 4,081 | 3,415 | $988K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6,684 | 5,831 | $705K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,709 | 4,277 | $688K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,788 | 2,310 | $629K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,227 | 1,901 | $421K |
| G0378 | Hospital observation service, per hour | 5,184 | 2,224 | $419K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6,375 | 4,729 | $412K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,983 | 1,116 | $392K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,066 | 2,253 | $391K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,650 | 3,405 | $386K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,410 | 1,175 | $292K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,489 | 2,016 | $272K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 593 | 475 | $232K |
| 80053 | Comprehensive metabolic panel | 38,422 | 32,734 | $203K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 927 | 727 | $165K |
| 93308 | 604 | 519 | $164K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,142 | 1,280 | $155K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,870 | 3,735 | $142K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 625 | 530 | $138K |
| 90839 | 1,027 | 823 | $118K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,036 | 98 | $90K |
| 82805 | 2,728 | 2,171 | $87K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 985 | 767 | $78K |
| 93975 | 696 | 594 | $78K | |
| 87631 | 500 | 464 | $72K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 329 | 273 | $69K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 111 | 95 | $66K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,553 | 6,452 | $62K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,652 | 3,816 | $60K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 463 | 449 | $55K |
| 93971 | 872 | 742 | $54K | |
| 70498 | 229 | 192 | $53K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,006 | 1,000 | $52K |
| 93970 | 454 | 374 | $49K | |
| 71046 | Radiologic examination, chest; 2 views | 9,693 | 8,558 | $49K |
| 64447 | 230 | 193 | $41K | |
| 71250 | 501 | 440 | $39K | |
| 84484 | 14,423 | 9,602 | $37K | |
| 12001 | 232 | 210 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 36,788 | 31,654 | $32K |
| 76770 | 224 | 201 | $30K | |
| 36415 | Collection of venous blood by venipuncture | 38,305 | 26,930 | $30K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 980 | 892 | $30K |
| 72131 | 444 | 375 | $28K | |
| 86850 | 1,375 | 1,157 | $28K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,644 | 2,296 | $27K |
| 97161 | 1,078 | 887 | $27K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 289 | 233 | $26K |
| 76830 | Ultrasound, transvaginal | 607 | 523 | $26K |
| 70491 | 86 | 69 | $25K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,654 | 1,378 | $25K |
| 97165 | 587 | 485 | $25K | |
| 80061 | Lipid panel | 2,208 | 1,943 | $24K |
| 81513 | 191 | 167 | $24K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 26,508 | 22,519 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,073 | 3,638 | $21K |
| 85027 | 10,471 | 8,253 | $20K | |
| 71045 | Radiologic examination, chest; single view | 9,646 | 8,486 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,118 | 983 | $20K |
| 83970 | 1,038 | 545 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,704 | 1,483 | $18K |
| 97116 | 967 | 567 | $18K | |
| 97535 | Self-care/home management training, each 15 minutes | 699 | 451 | $17K |
| 93799 | 3,368 | 1,137 | $17K | |
| 96367 | 598 | 446 | $16K | |
| C1776 | Joint device (implantable) | 46 | 38 | $15K |
| 64415 | 71 | 41 | $15K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 20,419 | 17,657 | $14K |
| 86900 | 1,386 | 1,161 | $14K | |
| 70486 | 565 | 483 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,611 | 7,330 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 313 | 301 | $14K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 37 | 37 | $13K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 107 | 81 | $13K |
| 72100 | 484 | 428 | $13K | |
| 97802 | 268 | 220 | $11K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 74 | 62 | $11K |
| 81001 | 25,411 | 22,596 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,096 | 3,659 | $11K |
| 84702 | 1,579 | 1,209 | $10K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 15 | 12 | $10K |
| 83735 | 18,233 | 14,981 | $10K | |
| 82728 | 671 | 575 | $10K | |
| 90715 | 642 | 547 | $9K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 28 | 25 | $9K |
| 82962 | 8,488 | 3,244 | $9K | |
| 76801 | 574 | 476 | $9K | |
| 73502 | 815 | 666 | $9K | |
| 80069 | 718 | 549 | $9K | |
| 86780 | 1,864 | 1,639 | $9K | |
| 76857 | 674 | 579 | $9K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 63 | 57 | $9K |
| 73030 | 1,103 | 896 | $9K | |
| 85610 | 6,681 | 4,650 | $9K | |
| 73564 | 886 | 779 | $8K | |
| 82607 | 669 | 568 | $8K | |
| 94060 | 104 | 90 | $8K | |
| A9270 | Non-covered item or service | 1,988 | 909 | $8K |
| 64450 | 76 | 51 | $8K | |
| 73630 | 1,300 | 1,143 | $8K | |
| 86803 | 424 | 355 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 484 | 414 | $7K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 313 | 252 | $7K |
| 86140 | 951 | 771 | $7K | |
| 84439 | 413 | 368 | $7K | |
| 83880 | 2,331 | 1,912 | $7K | |
| 76642 | 50 | 41 | $7K | |
| 83540 | 921 | 801 | $7K | |
| 96376 | 2,449 | 1,247 | $7K | |
| 73130 | 902 | 805 | $7K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 15 | 12 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,191 | 1,863 | $6K |
| 88307 | 56 | 40 | $6K | |
| 83550 | 912 | 790 | $6K | |
| 82570 | 639 | 562 | $5K | |
| 73610 | 1,038 | 902 | $5K | |
| 74018 | 337 | 288 | $5K | |
| 99215 | Prolong outpt/office vis | 146 | 127 | $5K |
| 97162 | 122 | 117 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 510 | 447 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 202 | 63 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,511 | 3,108 | $4K |
| 96368 | 197 | 126 | $4K | |
| 86901 | 1,386 | 1,161 | $4K | |
| 87340 | 382 | 299 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,539 | 2,146 | $4K |
| 70496 | 272 | 231 | $4K | |
| 73560 | 592 | 495 | $4K | |
| 73110 | 595 | 518 | $4K | |
| 10060 | 26 | 25 | $4K | |
| 12011 | 27 | 24 | $4K | |
| 80076 | 379 | 305 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 391 | 330 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | 6,634 | 5,076 | $4K |
| 82077 | 3,287 | 2,509 | $3K | |
| 84153 | 187 | 172 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 16 | 12 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,710 | 2,403 | $3K |
| 82043 | 491 | 439 | $3K | |
| 93017 | 44 | 37 | $3K | |
| 82310 | 254 | 147 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 15 | 14 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 579 | 457 | $2K |
| 84100 | 881 | 557 | $2K | |
| 99152 | 765 | 589 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 823 | 665 | $2K |
| 76536 | 27 | 25 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 514 | 234 | $2K |
| 73090 | 148 | 120 | $2K | |
| 82330 | 3,025 | 2,236 | $2K | |
| 94729 | 68 | 63 | $2K | |
| 83605 | 3,319 | 2,429 | $2K | |
| 95012 | 18 | 13 | $2K | |
| 87077 | 828 | 710 | $2K | |
| 80197 | 103 | 56 | $2K | |
| 85379 | 2,438 | 2,058 | $2K | |
| 83690 | 6,368 | 5,311 | $2K | |
| 73140 | 341 | 308 | $2K | |
| 12002 | 14 | 13 | $1K | |
| 74174 | 12 | 12 | $1K | |
| 84132 | 3,918 | 3,160 | $1K | |
| 82550 | 1,392 | 1,048 | $1K | |
| 73590 | 290 | 250 | $1K | |
| 80320 | 171 | 152 | $1K | |
| 81025 | 17,492 | 15,596 | $1K | |
| 85730 | 2,255 | 1,790 | $1K | |
| 86703 | 1,320 | 1,162 | $1K | |
| 85652 | 365 | 310 | $1K | |
| 73080 | 190 | 165 | $1K | |
| 76870 | 27 | 24 | $1K | |
| 84450 | 760 | 652 | $1K | |
| 82746 | 181 | 148 | $981.33 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 25 | 13 | $957.97 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,759 | 1,727 | $918.29 |
| 77061 | 28 | 24 | $886.28 | |
| 84460 | 725 | 630 | $859.28 | |
| 85018 | 2,761 | 2,206 | $796.50 | |
| 87186 | 650 | 564 | $790.87 | |
| 82375 | 2,706 | 2,180 | $769.70 | |
| 0002A | 23 | 23 | $721.62 | |
| 84550 | 122 | 107 | $709.45 | |
| 00731 | 436 | 362 | $706.42 | |
| 99221 | 59 | 56 | $689.08 | |
| 80143 | 565 | 464 | $679.22 | |
| 77065 | Tomosynthesis, mammo | 51 | 43 | $651.60 |
| J1170 | Injection, hydromorphone, up to 4 mg | 711 | 401 | $604.36 |
| 83050 | 2,683 | 2,143 | $596.01 | |
| 96127 | 18 | 16 | $565.80 | |
| 01400 | 307 | 247 | $559.12 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,288 | 1,078 | $535.18 |
| J1815 | Injection, insulin, per 5 units | 87 | 64 | $512.70 |
| 82435 | 2,282 | 1,848 | $481.49 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 12,210 | 10,157 | $474.46 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 943 | 684 | $471.03 |
| 90688 | 33 | 24 | $463.00 | |
| 0001A | 30 | 28 | $419.68 | |
| 84295 | 2,637 | 2,148 | $398.70 | |
| J2704 | Injection, propofol, 10 mg | 8,374 | 3,573 | $398.21 |
| 87430 | 1,375 | 1,293 | $380.22 | |
| 80179 | 553 | 457 | $371.12 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 340 | 135 | $332.98 |
| 00811 | 161 | 111 | $325.02 | |
| 00320 | 340 | 192 | $325.02 | |
| 86706 | 35 | 27 | $313.38 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,694 | 700 | $302.16 |
| 87070 | 205 | 179 | $290.30 | |
| 87040 | 785 | 598 | $283.09 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 453 | 319 | $276.23 |
| Q3014 | Telehealth originating site facility fee | 13 | 13 | $251.98 |
| J3490 | Unclassified drugs | 76 | 55 | $249.43 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 41 | 40 | $214.36 |
| 82553 | 20 | 15 | $214.23 | |
| 87481 | 39 | 38 | $212.61 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,200 | 5,226 | $211.46 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,299 | 1,714 | $204.54 |
| 73552 | 14 | 12 | $199.10 | |
| 71101 | 52 | 49 | $199.10 | |
| 81003 | 43 | 37 | $197.89 | |
| 87808 | 676 | 650 | $178.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,009 | 1,451 | $160.57 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 14 | 12 | $154.98 |
| 82565 | 15 | 12 | $145.52 | |
| J1790 | Injection, droperidol, up to 5 mg | 1,481 | 1,073 | $134.86 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,016 | 2,943 | $121.45 |
| 80164 | 32 | 25 | $118.30 | |
| 82784 | 15 | 12 | $118.12 | |
| Q0247 | Injection, sotrovimab, 500 mg | 22 | 21 | $114.85 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 250 | 147 | $106.48 |
| 82010 | 593 | 484 | $104.03 | |
| 87205 | 155 | 122 | $101.02 | |
| 72170 | 17 | 13 | $99.54 | |
| C9113 | Injection, pantoprazole sodium, per vial | 199 | 111 | $98.90 |
| 76937 | 13 | 12 | $96.42 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,201 | 1,526 | $94.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,904 | 5,875 | $92.88 |
| J2060 | Injection, lorazepam, 2 mg | 878 | 599 | $89.43 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 568 | 421 | $80.72 |
| 77066 | Tomosynthesis, mammo | 14 | 12 | $68.49 |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,415 | 942 | $65.30 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,406 | 913 | $58.35 |
| 83921 | 17 | 12 | $56.32 | |
| 82272 | 45 | 28 | $51.88 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 613 | 536 | $51.74 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,530 | 2,559 | $49.45 |
| 84145 | 29 | 26 | $47.05 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,684 | 2,014 | $45.13 |
| 36410 | 14 | 14 | $44.05 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,066 | 734 | $36.88 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 757 | 593 | $24.13 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 530 | 380 | $23.60 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 75 | 50 | $23.20 |
| J3370 | Injection, vancomycin hcl, 500 mg | 379 | 229 | $23.05 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 187 | 161 | $21.99 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,071 | 2,093 | $21.87 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 275 | 139 | $21.06 |
| J1940 | Injection, furosemide, up to 20 mg | 124 | 70 | $20.90 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 868 | 579 | $20.58 |
| 80177 | 30 | 14 | $15.77 | |
| J3480 | Injection, potassium chloride, per 2 meq | 341 | 236 | $14.56 |
| 87088 | 15 | 14 | $8.60 | |
| J1630 | Injection, haloperidol, up to 5 mg | 47 | 37 | $6.56 |
| J1171 | Injection, hydromorphone, 0.1 mg | 40 | 31 | $5.85 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 529 | 406 | $5.43 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 86 | 80 | $2.82 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,229 | 859 | $1.55 |
| 91300 | 58 | 44 | $0.33 | |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg | 29 | 13 | $0.24 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 25 | 13 | $0.16 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 14 | 12 | $0.10 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 419 | 250 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 173 | 152 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 26 | 26 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 16 | 13 | $0.00 |
| 01844 | 22 | 13 | $0.00 | |
| 3078F | 74 | 62 | $0.00 | |
| 87899 | 17 | 16 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 62 | 61 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 235 | 164 | $0.00 |
| C1769 | Guide wire | 378 | 292 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 245 | 203 | $0.00 |
| 94760 | 1,423 | 792 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 49 | 33 | $0.00 |
| 00813 | 68 | 54 | $0.00 | |
| 86308 | 27 | 26 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 25 | 12 | $0.00 |
| 88304 | 13 | 13 | $0.00 |